Present-day problems of diagnosis and treatment in the idiopathic thrombocytopenic purpura.
A review is made of the data in the literature and of the authors' experience regarding the etiology and pathogenesis, diagnosis and therapy of the chronic form of idiopathic thrombocytopenic purpura (ITP). The mechanisms of production (after McMillan et al.) are presented schematically and the five criteria of ITP diagnosis suggested by Karpatkin are discussed: 1) decreased blood platelet count with direct or indirect signs of thrombocytolysis; 2) increased number of megakaryocytes in the bone marrow and/or signs of intramedullary thrombocytolysis; 3) direct or indirect signs of antiplatelet autoantibody presence in the plasma; 4) exclusion of a primary disorder and 5) absence of splenomegaly. The results of corticotherapy, splenectomy, platelet transfusion and immunosuppression (including "target" immunosuppressive therapy) in 188 patients with ITP, admitted to the clinic of Hematology--Bucharest between 1966 and 1978, are presented and analysed.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001803:Blood Transfusion; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010956:Plasmapheresis; D017713:Platelet Transfusion; D011696:Purpura, Thrombocytopenic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D013156:Splenectomy
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents